Intellia Therapeutics (NTLA) Insider Trading & Ownership $9.50 +0.08 (+0.85%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Intellia Therapeutics (NASDAQ:NTLA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.20%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$473,221.70 Get NTLA Insider Trade Alerts Want to know when executives and insiders are buying or selling Intellia Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NTLA Insider Buying and Selling by Quarter Intellia Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/3/2025John M LeonardCEOSell26,807$12.18$326,509.26 1/3/2025Michael P DubeCAOSell1,372$12.18$16,710.96 1/2/2025Eliana ClarkEVPSell556$12.03$6,688.68 10/2/2024Michael P DubeCAOSell2,012$19.01$38,248.12 7/1/2024Eliana ClarkEVPSell405$22.93$9,286.65 3/4/2024James BastaEVPSell2,297$32.99$75,778.03 (Data available from 1/1/2013 forward) NTLA Insider Trading Activity - Frequently Asked Questions Who is on Intellia Therapeutics's Insider Roster? The list of insiders at Intellia Therapeutics includes David Lebwohl, Eliana Clark, Glenn Goddard, James Basta, John M Leonard, Laura Sepp-Lorenzino, Michael P Dube, and Muna Bhanji. Learn more on insiders at NTLA. What percentage of Intellia Therapeutics stock is owned by insiders? 3.20% of Intellia Therapeutics stock is owned by insiders. Learn more on NTLA's insider holdings. Which Intellia Therapeutics insiders have been selling company stock? The following insiders have sold NTLA shares in the last 24 months: David Lebwohl ($172,134.78), Eliana Clark ($255,558.93), Glenn Goddard ($158,052.90), James Basta ($75,778.03), John M Leonard ($892,818.84), Laura Sepp-Lorenzino ($65,679.25), Michael P Dube ($54,959.08), and Muna Bhanji ($90,924.05). How much insider selling is happening at Intellia Therapeutics? Insiders have sold a total of 73,912 Intellia Therapeutics shares in the last 24 months for a total of $1,765,905.86 sold. Intellia Therapeutics Key ExecutivesDr. John M. Leonard M.D. (Age 67)President, CEO & Director Compensation: $1.06MMr. Glenn G. Goddard CPA (Age 53)Executive VP, CFO & Treasurer Compensation: $630.91kDr. Laura Sepp-Lorenzino Ph.D. (Age 63)Executive VP & Chief Scientific Officer Compensation: $670.58kMr. James E. Basta Esq. (Age 58)J.D., Executive VP, General Counsel & Corporate Secretary Compensation: $616.15kDr. David Lebwohl M.D. (Age 69)Executive VP & Chief Medical Officer Compensation: $671.42kMr. Derek Hicks (Age 50)Executive VP & Chief Business Officer Compensation: $823.42kMr. Nessan Bermingham Ph.D. (Age 51)Founder & Member of Scientific Advisor Board Compensation: $1.38MDr. Rachel E. Haurwitz Ph.D. (Age 38)Co-Founder Dr. Andrew May Ph.D.Founder and Member of Scientific Advisor BoardDr. Jennifer A. Doudna Ph.D. (Age 60)Founder & Member of Scientific Advisor Board More Insider Trading Tools from MarketBeat Related Companies Organon & Co. Insider Selling ADMA Biologics Insider Selling Ultragenyx Pharmaceutical Insider Selling Verona Pharma Insider Selling Biohaven Insider Selling Crinetics Pharmaceuticals Insider Selling Arcellx Insider Selling Apellis Pharmaceuticals Insider Selling PTC Therapeutics Insider Selling Avidity Biosciences Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:NTLA) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredTop Picks for Trump’s Pro-Crypto AmericaThe Crypto ETF Windfall: 27 Experts Tell All (Free) Don't miss your chance to see exactly what crypto's eli...Crypto 101 Media | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intellia Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intellia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.